Business context and reporting period
UAS Drone Corp. (OTCQB: USDR), which owns Duke Robotics and its Israeli subsidiary, filed this unaudited Form 10-Q for the quarter ended March 31, 2024. The request identifies the company as DUKE Robotics Corp.; the filing’s registrant is UAS Drone Corp. The company develops the TIKAD robotic stabilization system for remote, accurate firing and an insulator-cleaning drone for utility infrastructure. Its IEC agreement was completed in October 2023. The filing reports no revenue in either comparable quarter.
Key financial metrics
Amounts are in thousands of U.S. dollars, except per-share data.
| Metric | Q1 2024 | Q1 2023 or comparison |
|---|---|---|
| Revenue | $0 | $0 |
| Research and development expense | $38 | $0 |
| General and administrative expense | $192 | $202 |
| Operating loss | $230 | $202 |
| Net financing income | $21 | $23 |
| Net loss | $209 | $179 |
| Basic and diluted loss per share | $0.00 loss | $0.00 loss |
| Cash used in operations | $169 | $209 |
| Cash used in investing | $0 | $16 |
Gross margin is not meaningful because the company reported no revenue. Cash and cash equivalents were $2,112 at March 31, 2024, down from $2,281 at December 31, 2023. Total assets were $2,274; current assets were $2,135 and current liabilities $311. Total liabilities were $660, including $316 of related-party loans and $85 of operating lease liabilities. Stockholders’ equity was $1,614. The filing does not provide a conventional debt balance apart from the disclosed related-party loans and lease obligations.
Material changes versus the prior comparable period
- Net loss widened by $30, from $179 to $209, as $38 of R&D spending began after the IEC work was completed.
- G&A declined by $10 to $192, primarily because share-based compensation decreased; share-based compensation was $15 versus $39.
- Operating cash use improved by $40 to $169, mainly reflecting the net loss and a decrease in other current assets.
- Cash fell by $169 during the quarter. The share count remained 54,218,813 at quarter-end.
Outlook, risks, contingencies and unusual items
- Management said existing cash is expected to fund obligations for more than 12 months from approval of the statements and at least the next 12 months. It cautioned that cash could be consumed faster than expected and that additional financing may be needed; financing may not be available on acceptable terms or at all.
- The company described its business as start-up in nature and identified commercialization, product development, manufacturing expansion, marketing, regulatory approvals and capital availability as risks. It has no revenue to date in the reported quarters.
- Management could not assess the medium- or long-term effects of the Israel war and regional hostilities. The filing warns that disruptions, including employees or service-provider personnel being called to reserve duty, could impair operations and the ability to meet customer or vendor obligations.
- The company reported 2,426,812 outstanding options, none granted or exercised in the quarter. It also disclosed warrants from a 2021 private placement extended to expire November 11, 2024.
- Disclosure controls and procedures were concluded to be ineffective as of March 31, 2024; no material change in internal control over financial reporting was reported during the quarter.
- On May 12, 2024, the board approved increasing director Erez Nachtomy’s monthly compensation from $6,950 to $10,000.
- No off-balance-sheet arrangements were reported. The filing provides no specific revenue or earnings guidance.
Important facts for investors to verify
- Confirm the issuer and security: the filing is by UAS Drone Corp. (USDR), notwithstanding the request’s DUKE Robotics Corp. label.
- Monitor whether the company converts its product development and partnerships into commercial sales, given the absence of revenue.
- Assess cash burn, the stated liquidity runway and any need for additional financing.
- Track operational effects of regional hostilities and progress in commercialization, regulatory approvals and manufacturing.
- Review remediation of ineffective disclosure controls, the November 2024 warrant expiration and the implications of related-party loans and director compensation.